Location History:
- Elkhorn, NE (US) (2013)
- Omaha, NE (US) (2012 - 2019)
Company Filing History:
Years Active: 2012-2019
Title: The Innovative Contributions of Terri L. Wasmoen
Introduction
Terri L. Wasmoen is a prominent inventor based in Elkhorn, NE (US). She has made significant contributions to the field of veterinary medicine, particularly in the development of vaccines for bovine diseases. With a total of 6 patents to her name, her work has had a substantial impact on animal health.
Latest Patents
One of her latest patents is titled "Attenuated Bovine Coronavirus and Related Vaccines." This invention discloses novel attenuated bovine coronavirus isolates, compositions comprising these isolates, and methods of using such compositions in vaccines, including live vaccines. The invention further details the administration of such vaccines, including intranasal administration, to aid in the prevention of respiratory disease caused by bovine coronavirus. Another significant patent is "Vaccines with Live Bacterial Isolates for Systemic Administration." This invention pertains to vaccines suitable for systemic administration that comprise live aro mutant bacteria, an adjuvant, an aromatic supplement, or both. It also covers the manufacture of such a vaccine and a method of protecting an animal through its administration.
Career Highlights
Terri has worked with notable organizations such as Intervet Inc. and Louisiana State University and Agricultural & Mechanical College. Her experience in these institutions has allowed her to advance her research and contribute to the development of innovative veterinary solutions.
Collaborations
Throughout her career, Terri has collaborated with several professionals in her field, including Rhonda LaFleur and Steven M. Callister. These collaborations have enriched her work and expanded the impact of her inventions.
Conclusion
Terri L. Wasmoen's contributions to veterinary medicine through her innovative patents demonstrate her commitment to improving animal health. Her work continues to influence the development of effective vaccines for bovine diseases, showcasing the importance of innovation in this field.